000 01423 a2200397 4500
005 20250517005109.0
264 0 _c20150928
008 201509s 0 0 eng d
022 _a2042-6984
024 7 _a10.1002/alr.21443
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchaffer, Frederick M
245 0 0 _aThe safety of self-administered allergen immunotherapy during the buildup and maintenance phases.
_h[electronic resource]
260 _bInternational forum of allergy & rhinology
_cFeb 2015
300 _a149-56 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic alpha-Agonists
_xtherapeutic use
650 0 4 _aAdult
650 0 4 _aAllergens
_xadverse effects
650 0 4 _aDesensitization, Immunologic
_xadverse effects
650 0 4 _aEpinephrine
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypersensitivity, Immediate
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPatient Safety
650 0 4 _aRhinitis, Allergic, Perennial
_xtherapy
650 0 4 _aRhinitis, Allergic, Seasonal
_xtherapy
650 0 4 _aSelf Administration
700 1 _aNaples, Andrew R
700 1 _aEbeling, Myla
700 1 _aHulsey, Thomas C
700 1 _aGarner, Larry M
773 0 _tInternational forum of allergy & rhinology
_gvol. 5
_gno. 2
_gp. 149-56
856 4 0 _uhttps://doi.org/10.1002/alr.21443
_zAvailable from publisher's website
999 _c24429325
_d24429325